bluebird bio Income Statement

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	92.49	83.72	87.62	44
Revenue Growth (YoY)	10.47%	-4.44%	99.14%	-
Cost of Revenue	63.11	57.85	68.13	29.87
Gross Profit	29.38	25.88	19.49	14.13
Selling, General & Admin	8.2	6.51	6.03	3.94
Operating Expenses	8.38	6.72	6.27	4.19
Operating Income	21	19.16	13.22	9.93
Interest Expense	-0.03	-0.03	-0.13	-0.11
Interest & Investment Income	0.03	0.03	0.01	-
Other Non Operating Income (Expenses)	1.19	0.22	0.56	0.21
EBT Excluding Unusual Items	22.19	19.39	13.66	10.03
Gain (Loss) on Sale of Investments	0.12	0.04	-0.18	-0
Gain (Loss) on Sale of Assets	-	-	0.04	-0.03
Asset Writedown	-	-	3.94	1.97
Pretax Income	22.31	19.44	17.46	11.98
Income Tax Expense	1.11	1.23	0.44	0.31
Net Income	21.2	18.22	17.01	11.67
Net Income to Common	21.2	18.22	17.01	11.67
Net Income Growth	16.41%	7.07%	45.80%	-
Shares Outstanding (Basic)	33	32	30	-
Shares Outstanding (Diluted)	33	32	30	-
Shares Change (YoY)	3.61%	6.16%	-	-
EPS (Basic)	0.64	0.57	0.57	-
EPS (Diluted)	0.64	0.57	0.57	-
EPS Growth	12.35%	0.85%	-	-
Free Cash Flow	-62.12	11.01	-0.95	-0.77
Free Cash Flow Per Share	-1.88	0.35	-0.03	-
Dividend Per Share	0.300	0.300	-	-
Gross Margin	31.77%	30.90%	22.24%	32.10%
Operating Margin	22.70%	22.88%	15.09%	22.57%
Profit Margin	22.93%	21.76%	19.42%	26.52%
Free Cash Flow Margin	-67.16%	13.16%	-1.09%	-1.75%
EBITDA	21.18	19.37	13.46	10.19
EBITDA Margin	22.90%	23.14%	15.36%	23.16%
D&A For EBITDA	0.19	0.21	0.24	0.26
EBIT	21	19.16	13.22	9.93
EBIT Margin	22.70%	22.88%	15.09%	22.57%
Effective Tax Rate	4.96%	6.31%	2.54%	2.56%
Advertising Expenses	0.25	0.35	0.7	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.